Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0001104659-22-103472
Filing Date
2022-09-28
Accepted
2022-09-28 06:02:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 SC TO-I tm2226621-1_sctoi.htm SC TO-I 89316
2 EX-99.(A)(1)(I) tm2226621d1_exhiai.htm EX-99.(A)(1)(I) 408750
3 EX-99.(A)(1)(II) tm2226621d1_exhiaii.htm EX-99.(A)(1)(II) 272925
4 EX-99.(A)(1)(III) tm2226621d1_exhiaiii.htm EX-99.(A)(1)(III) 53357
5 EX-99.(A)(1)(IV) tm2226621d1_exhiaiv.htm EX-99.(A)(1)(IV) 18555
6 EX-99.(A)(1)(V) tm2226621d1_exhiav.htm EX-99.(A)(1)(V) 66534
7 EXHIBIT 99.(A)(1)(VI) tm2226621d2_exa1vi.htm EX-99.(A)(1)(VI) 31287
8 EXHIBIT 99.(A)(5)(II) tm2226621d2_exa5ii.htm EX-99.(A)(5)(II) 13706
9 EXHIBIT 99.(D)(8) tm2226621d2_exd8.htm EX-99.(D)(8) 52024
10 EX-FILING FEES tm2226621d2_ex-filingfees.htm EX-FILING FEES 8980
11 GRAPHIC tm2226621d2_exa5iiimg001.jpg GRAPHIC 5213
  Complete submission text file 0001104659-22-103472.txt   1024425
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filed by) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-88552 | Film No.: 221272693
SIC: 2834 Pharmaceutical Preparations